In addition, analyses of tissue microarrays (TMA) showed that low levels of FBXL2 expression were observed in 66.67% (50 of 75) in human lung squamous cell carcinoma (LUSC) compared to adjacent tissues (Fig. 3b). The gene discussed is FBXL2; the disease is squamous cell lung carcinoma.